Search alternatives:
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
we decrease » _ decrease (Expand Search), mean decrease (Expand Search), teer decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
w decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
we decrease » _ decrease (Expand Search), mean decrease (Expand Search), teer decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
w decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
701
Pharmacological Mechanism of the Non-hallucinogenic 5‑HT<sub>2A</sub> Agonist Ariadne and Analogs
Published 2022“…Compared to DOM, Ariadne shows lower signaling potency and efficacy in multiple signaling pathways examined (G<sub>q</sub>, G<sub>11</sub>, and β-arrestin2) coupled to 5-HT<sub>2A</sub> receptors. We confirmed the shift in signaling for an α-propyl analog and provide a molecular docking rationale for the progressive decrease in signaling potency with the growing length of the α-substituent. …”
-
702
Pharmacological Mechanism of the Non-hallucinogenic 5‑HT<sub>2A</sub> Agonist Ariadne and Analogs
Published 2022“…Compared to DOM, Ariadne shows lower signaling potency and efficacy in multiple signaling pathways examined (G<sub>q</sub>, G<sub>11</sub>, and β-arrestin2) coupled to 5-HT<sub>2A</sub> receptors. We confirmed the shift in signaling for an α-propyl analog and provide a molecular docking rationale for the progressive decrease in signaling potency with the growing length of the α-substituent. …”
-
703
-
704
-
705
-
706
-
707
-
708
-
709
-
710
Characteristics of participants in the surveys included in the present review per region.
Published 2016Subjects: -
711
-
712
-
713
-
714
Drug resistance mutation frequency comparison, 2000–2005 vs. 2006–2015, for Brazil.
Published 2016Subjects: -
715
Drug resistance mutation frequency comparison, 2000–2005 vs. 2006–2015, for the Caribbean.
Published 2016Subjects: -
716
Drug resistance mutation frequency comparison, 2000–2005 vs. 2006–2015, for the Southern Cone.
Published 2016Subjects: -
717
Drug resistance mutation frequency comparison, 2000–2005 vs. 2006–2015, for the Andean region.
Published 2016Subjects: -
718
Drug resistance mutation frequency comparison, 2000–2005 vs. 2006–2015, for the Mesoamerican region.
Published 2016Subjects: -
719
Drug resistance mutation frequency comparison, 2000–2005 vs. 2006–2015, for the whole LAC region.
Published 2016Subjects: -
720
<i>Ext1</i> mutant lungs exhibit a decrease in SHH-FGF10 signaling.
Published 2017“…<p>(A) qPCR analysis of key components of FGF signaling pathway in lungs from E14.5. …”